Climb Bio, Inc.
Clinical trials sponsored by Climb Bio, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New lupus drug candidate enters first human tests Results expected Apr 2027 (estimated)
- New antibody drug aims to boost platelets in Hard-to-Treat ITP Results expected Aug 2027 (estimated)
- New antibody therapy aims to tame lupus in early trial Results expected Sep 2027 (estimated)